InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-20.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Kamdar Kim P.. Officer active across 4 companies, notably Singular Genomics Systems, Inc.. Aggregated, 10 reports have been recorded. Breakdown: 1 buy · 2 sells. Total volume traded: €202k. Activity tracked since 18 June 2021. The latest transaction was filed on 10 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Kamdar Kim P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
22,426 shares0Class A Common StockSEC:0001535065-26-000002:0
3,421 shares0Class A Common StockSEC:0001535065-26-000002:1
30,920 shares0Class A Common StockSEC:0001193125-26-037807:0
15,596 shares0Class A Common StockSEC:0000950170-25-083335:0
15,000 sharesCommon StockSEC:0000950170-25-027096:0
7,117 shares0Class A Common StockSEC:0001534969-24-000133:0
10 shares@ US$0.621100.0% of flowCommon StockSEC:0001493152-23-045912:0
353,657 shares@ US$0.5955100.0% of flowCommon StockSEC:0001209191-23-045925:0
10,000 shares@ US$1.165100.0% of flowCommon StockSEC:0001618835-21-000156:0
Canonical exit: 16 Sept 2021 (T+90)
4,395,633 sharesCommon StockSEC:0000904454-21-000498:0
10 of 10 declarations
About Kamdar Kim P.
Kamdar Kim P. is a Director at Sera Prognostics, INC., Singular Genomics Systems, Inc. and Evofem Biosciences, Inc. The declarant has 10 filings in total; across the 10 sampled filings, buys total 9779 EUR and sells total 191783 EUR, with a date range from 2021-06-01 to 2026-07-14. The modal transaction nature is Attribution.
